Follow on Google News News By Tag Industry News * Molecular Diagnostic Market * More Industries... News By Place Country(s) Industry News
Follow on Google News | Global Molecular Diagnostics Market Report : 2012 Edition - New Report by Koncept AnalyticsThe current report analyzes the global molecular diagnostic market. It also presents a view of the various segments of the market. It discusses the drivers and challenges prevailing in the molecular diagnostics industry and includes company profiles.
Testing for established infectious diseases such as HPV, CT/GC, and hepatitis, among others, represents the largest market category in terms of revenue generation. However, with the realm of molecular diagnostic testing in cancer screening undergoing a major change, the Oncology segment of the market will witness significant expansion in the times to come, driving the overall market for molecular diagnostics. Geographically, the US is the largest regional market in worldwide molecular diagnostics industry, with Europe and Japan trailing behind the US. While, these regions will continue to dominate the molecular diagnostics landscape, the emerging regions are expected to experience the fastest growth. This report includes the following sections: 1. Overview 1.1 In Vitro Diagnostics: 1.2 Molecular diagnostics 2. Global Market Structure 2.1 Global IVD Market 2.1.1 Global Market Size 2.1.2 Market Segmentation 2.1.3 Competitive Scenario in IVD Market 2.2 Global Molecular Diagnostics Market 2.2.1 Global Market Size 2.2.2 Market by Segments 2.2.3 Market by Regions 2.3 Molecular Diagnostics Segments Analysis 2.3.1 HPV 2.3.2 CT/GC 2.3.3 Influenza 3. Molecular Diagnostics - Market Dynamics 3.1 Trends & Developments 3.1.1 Molecular Diagnostics in Oncology: Focus on Personalized Treatment 3.1.2 Growing M&A Activity in the Molecular Diagnostics Landscape 3.1.3 Emerging Korean Molecular Diagnostics Business 3.1.4 Growth in Genetic Testing 3.1.5 Development of Industry’s First Real-Time “Multiplex Quantification” 3.3 Growth Drivers 3.3.1 Growing Ageing Population 3.3.2 Rising Demand for Better Healthcare Options 3.3.3 Rise in Healthcare Spending 3.4 Challenges 3.4.1 Increasing Safety Regulations 3.4.2 Escalating Price Pressure 4. Molecular Diagnostics - Competitive Scenario Competitive Overview Market Share Peer Comparison 5. Company Profiles 5.1 Roche Holdings AG Business Description Key Financials Business Strategies Focus On Innovative Diagnostics Leverage Expertise in Molecular Biology 5.2 Novartis AG Business Description Key Financials Business Strategies Sustained Investment in Innovation Expansion in High-Growth Markets 5.3 Qiagen N.V. Business Description Key Financials Business Strategies Complete Automation Systems Continuously Adding New Test Content 5.4 Gen-Probe Incorporated Business Description Key Financials Business Strategies Expanding Product Portfolio Market Expansion within Clinical Diagnostics 6. Market Outlook 6.1 Market Forecast 6.2 Forecast Methodology 6.2.1 Dependent and Independent Variables 6.2.2 Correlation Analysis 6.2.3 Regression Analysis List of Charts IVD Market – Segments by Technology Molecular Diagnostcs – Traditional Process Main Purposes of Molecular Diagnostics Global In-Vitro Diagnostics Market Revenues, 2004-2010 Growth in Global In-Vitro Diagnostics Market, 2005-2016F Global IVD Market Classification by Segments, 2011 Global IVD Market by Regions, 2010 & 2015F Market Share of Leading Players in the Global IVD Market, 2010 Global Molecular Diagnostics Market, 2007-2011 Global Molecular Diagnostics Market Breakup by Segments, 2010 & 2015F Global Molecular Diagnostics Market Breakup by Application Areas, 2010 Global Molecular Diagnostics Market Breakdown by Regions, 2010 Number of Molecular Diagnostic Products Approved in the US, 2010 Global Molecular HPV Testing Market, 2010-2013E HPV Testing Market Penetration Rates in the US, 2010-2013E Global CT/GC Market Revenues, 2011 Global CT/GC Market Share by Leading Companies, 2011 The US Market for Influenza Diagnostic Tests, 2010 Current Standards of Care in Various Therapeutic Areas, 2011 Mergers & Acquisitions in Molecular Diagnostics Sector, 2008-2010 Number of Genetic Tests and Laboratories Available Worldwide, 1993-2011 Global Ageing Population, 2005-2013F Global Healthcare Spending, 2005-2010 Global Molecular Diagnostic Market Share by Companies, 2011 Leading Players in PCR Based Global Molecular Diagnostics Market, 2010 Roche’s Revenues by Business Segments, 2011 Roche’s Revenues and Net Income, 2007-2011 Novartis’ Revenues by Business Segments, 2011 Novartis’ Revenues and Net Income, 2007-2011 Qiagen’s Revenues Share by Source of Revenues, 2011 Qiagen’s Revenues and Net Income, 2007-2011 Gen-Probe’s Revenues Share by Source of Revenues, 2011 Qiagen’s Revenues and Net Income, 2007-2011 Global Molecular Diagnostics Market Forecast, 2010-2014F List of Tables Patients Worldwide Waiting for Better Treatment Options, 2011 Non-PCR Amplification Processes Global Peer Comparison in the Molecular Diagnostics Market, 2011 Global Molecular Diagnostic Companies – Proprietary Technology Dependent & Independent Variables, 2004-2010 Correlation Matrix Model Summary – Coefficient of Determination Regression Coefficients Output For further details, kindly visit http://www.konceptanalytics.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|